DWC202206

N/A

Report date: 2026/05/02 20:00:18

Base Information

Drug NameDWC202206
Drug Alias NameDWC-202206DWC202206
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHyperlipidemiasHypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesDaewoong Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsHyperlipidemiasHypertension
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A